|
|||||
|
|
Glucosuric,renal and haemodynamic effects of licogliflozin,a dual inhibitor of sodium-glucose co-transporter-1 and sodium-glucose co-transporter-2, in patients with chronic kidney disease: A randomized trial |
|
| Authors: | YanLing He PhD Alok Pachori PhD Ping Chen PhD Shenglin Ma PhD Anisha E Mendonza PhD Ahmed Amer MD Thomas C Marbury MD Markus Hinder MD |
| Institution: | 1. Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, USA;2. Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA;3. Orlando Clinical Research Center, Orlando, Florida, USA;4. Novartis Institutes for BioMedical Research, Basel, Switzerland |
| Abstract: | |
| Keywords: | drug mechanism phase I-II study |